Broker Name: DBS

Date of Report: 2024 (inferred from market data cited)

Excerpt from DBS report.

Report Summary

• Ultragreen dominates the global indocyanine green (ICG) market with over 60% share, leveraging regulatory barriers and strong product positioning to sustain high margins and growth.
• The ICG market is expected to grow at 11.7% CAGR to 2030, with Ultragreen’s earnings projected to rise at 23% CAGR from FY24-27, driven by increasing adoption, international expansion, and robust pricing power.

Above is an excerpt from a report by DBS. Clients of DBS can be the first to access the full report from the DBS website: https://www.dbs.com